Clinical Trials Logo

Overweight and Obesity clinical trials

View clinical trials related to Overweight and Obesity.

Filter by:

NCT ID: NCT04686552 Completed - Clinical trials for Overweight and Obesity

Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses

CINNI
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects

NCT ID: NCT04677738 Completed - Obesity Clinical Trials

Investigation of the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Overweight has become a critical issue in North America and the market value of weight loss products is expected to rise as the population becomes more health-conscious and aware of the risks associated with excess body weight. This randomized, placebo-controlled, clinical trial investigates the effect of Bifidobacterium breve supplementation with exercise intervention on fat loss.

NCT ID: NCT04658875 Not yet recruiting - Clinical trials for Overweight and Obesity

Effect of Spirulina Maxima and Exercise on General Fitness and Blood Lipids in Older Adults

Start date: January 17, 2022
Phase: N/A
Study type: Interventional

The global older adult population has grown more than any other age group, which could be explained by the decrease of birth rate and increase of life expectancy. The healthy life expectancy of older adult in Mexico is 65.8 years, and the population's life expectancy in general is 74.4 years, this means that the population meeting that age is at increased risk of developing some disease or dependence during approximately nine years of their life. For the population over 60 years, the three most frequent health conditions reported were hypertension (40%), diabetes (24.3%), and hypercholesterolemia (20.4%). In this sense, the search for a healthy lifestyle is necessary, which includes a healthy diet that includes supplementation with nutraceuticals and the daily practice of physical activity. Regarding nutraceutical supplementation, the cyanobacterium Spirulina maxima (S. maxima) is an important source of proteins, carotenoids, phenolic compounds and polyunsaturated fatty acids which have been tested for diverse biological activities such as lipid lowering effects, however, existing studies of effects of S. maxima on body composition, physical function and blood lipid profile in humans, mainly in older adults, have a low level of evidence and absence of adequate experimental designs, so its value as a nutraceutical cannot be assured. The effects of performing systematic physical exercise in older adults have been shown to have positive effects on body composition and blood lipid profile, so in the present study it is proposed to evaluate the synergy presented by a supplement such as S. maxima in a systematic physical exercise program on the body composition, physical function and blood lipid profile of sedentary older adults with excess weight in a randomized, double-blind, crossover, placebo controlled trial.

NCT ID: NCT04647149 Completed - Obesity Clinical Trials

Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity

Start date: September 3, 2019
Phase: N/A
Study type: Interventional

Time-restricted eating (TRE) is a dietary approach that aims to increase fasting time and decrease the eating window. Promising TRE effects on weight loss and some cardiometabolic risk factors have been reported. However, there is a lack of randomized clinical trials that directly investigate the effect of TRE at different times of the day (early vs. delayed) in individuals with overweight and obesity. The present study investigates the effects of 8 weeks of TRE performed at different moments of the day on body composition and cardiometabolic parameters in adults with overweight and obesity.

NCT ID: NCT04645108 Completed - Obesity Clinical Trials

Coached or Non-Coached Weight Loss Intervention

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

To evaluate the effect of one-on-one coaching in the Noom Healthy Weight Program, a digital behavior change, weight loss intervention, compared to the same program with no coaching, as well as influential factors.

NCT ID: NCT04639076 Completed - Clinical trials for Overweight and Obesity

Study of a Personalized vs. Standard Approach to Weight Loss Recommendations

mPWR
Start date: October 21, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and test the feasibility of a behavioral weight loss intervention that uses personalized recommendations for diet and physical activity behaviors in a behavioral weight loss program and to explore factors associated with treatment adherence and response. The 12-week intervention will utilize digital tools for self-monitoring and counseling by weight management professionals. Exploratory analyses will be conducted to determine if there are genetic, metabolomic, microbiome, or psychosocial factors associated with treatment response.

NCT ID: NCT04633044 Completed - Clinical trials for Overweight and Obesity

Maternal Betaine Supplementation During Breastfeeding

BetMilk
Start date: February 11, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Developing more efficient and cost-effective prevention strategies to slow down the worldwide epidemic of obesity and chronic metabolic disease has become a public health imperative. Our previous results in humans demonstrate that lower breast milk betaine levels were associated with faster infant postnatal growth, a strong and potentially modifiable risk factor of future obesity. Betaine is a trimethylated derivative of glycine, which is present in multiple foods and occurs naturally in breast milk. In this study, we will perform a double-blind randomized placebo-controlled pilot clinical study, in which maternal diet will be supplemented with betaine for 3 months during breastfeeding; infant's growth and adiposity will be monitored until 12 months of age, and breast milk composition and gut microbiota analyzed.

NCT ID: NCT04631913 Active, not recruiting - Healthy Clinical Trials

Meta-analysis of Oats for Diabetes Prevention and Management

Start date: August 14, 2020
Phase:
Study type: Observational

Oats are a commonly consumed source of viscous soluble fibre, which has an established role in cardiovascular disease risk management including in cholesterol and glycemic control. Oat beta-glucan is recognized for its cholesterol-lowering effects with approved health claims in Canada, US and Europe. However, the efficacy of oat beta-glucan on glycemic control is not clear. We propose to conduct a systematic review and meta-analysis to explore the efficacy of whole grain oats and oat beta-glucan on markers of glycemic control in people with, without or at risk for diabetes.

NCT ID: NCT04628624 Completed - Clinical trials for Overweight and Obesity

Green Tea Supplementation, Fat Oxidation and Body Composition in Overweight Individuals

GreenTea
Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of green tea extract (GTE) on fat oxidation, body composition and exercise performance in overweight individuals. The study will be conducted under laboratory conditions following an 8 week supplemental period. Participants will be required to attend the laboratory for a pre-screening/familiarisation trial followed by assessments at week 0 (baseline), week 2, 4 and 8. Across the intervention, participants will maintain habitual dietary intake and follow a prescribed exercise programme. Additionally participants will be randomised to either a placebo, green tea extract or GTE with antioxidant supplementation. It is hypothesised that the addition of antioxidants with GTE will enhance fat oxidation in overweight individuals more than GTE or placebo. It is further hypothesised that such improvements in fat oxidation due to GTE will lead to improvements in both body composition variables and submaximal exercise performance (metabolic efficiency) in overweight, but otherwise healthy persons.

NCT ID: NCT04624087 Completed - Clinical trials for Overweight and Obesity

Go/No-Go Intervention for Weight Loss

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.